Concepedia

Daniel Röshammar

DR

Statistics

Publications

16

Citations

727

H-Index

14

Active since

2006

Affiliations

University of Gothenburg(Current)

AstraZeneca (Sweden)

Karolinska University Hospital

Makerere University

Karolinska Institutet

Daniel Röshammar is an author at University of Gothenburg specializing in pharmacology, pharmacokinetics, and pharmacy.

Publications per year

2006–2023

16

Publications

16

High prevalence of the CYP2B6 516G→T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe

Christopher Nyakutira, Daniel Röshammar, Emmanuel Chigutsa et al. · European Journal of Clinical Pharmacology · 2007 · 214 citations

, , +17

A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single‐dose efavirenz population pharmacokinetics in Ugandans

Jackson Mukonzo, Daniel Röshammar, Paul Waako et al. · British Journal of Clinical Pharmacology · 2009 · 137 citations · Full text

, , +17

<i>In silico</i>prediction of efavirenz and rifampicin drug–drug interaction considering weight and CYP2B6 phenotype

Dinko Rekić, Daniel Röshammar, Jackson Mukonzo et al. · British Journal of Clinical Pharmacology · 2010 · 53 citations · Full text

, , +17

Population pharmacokinetics of amodiaquine and desethylamodiaquine in pediatric patients with uncomplicated falciparum malaria

Sofia Friberg Hietala, Achuyt Bhattarai, Mwinyi Msellem et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2007 · 49 citations

, , +14

Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects

Daniel Röshammar, Trinh Ngoc Hai, Sofia Friberg Hietala et al. · European Journal of Clinical Pharmacology · 2006 · 47 citations

, , +7

1–5 of 16